TopFunds

Align Technology

NASDAQ: ALGN

Stock price

176.2 USD

(+0%) TODAY

Health Care SuppliesMedical - Devices

Financial Performance

Share

5Y price score: (99)

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 84.2%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    122.0

    52-week range

    200.4

    176.2

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    6 %

    Dividend Yield TTM

    -

    Market cap $

    $ 12,619

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    30.6

    Price / Book TTM

    3

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    57.3

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    20.9 %

    (74.5) %

    84.2 %

    Free cash flow per share growth

    (18.6) %

    5.6 %

    198.7 %

    Earnings per share growth

    0.5 %

    (74.8) %

    219.2 %

    Founded: 1,997

    Employees: 21,200

    Business Summary:Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    2026 Q2 (Jul 29, 2026)

    1) Q2 2026 Performance Overview
    - Align Technology reported record revenues of $1.06 billion, up 4.3% YoY.
    - Clear Aligner volumes reached 692,000 cases, with revenue growth of 8.2% YoY.
    - Non-GAAP operating margin was 22.9%, exceeding expectations.
    - Strong performance driven by growth in APAC, EMEA, and Latin America, with stable North American results.

    2) Segment Results: Clear Aligners vs. Systems and Services
    - Clear Aligners: Revenue of $870.9 million, driven by higher volumes and ASPs. Average shipment price increased to $1,260.
    - Systems and Services: Revenue of $185.3 million, down 10.8% YoY due to lower scanner ASPs and a shift towards leasing and rental models.
    - Scanner placements increased double digits YoY, indicating strong adoption despite revenue decline.

    3) Strategic Initiatives and Governance
    - Align announced plans to add three new independent directors to enhance board expertise.
    - A comprehensive strategic and operating model review is underway to improve execution and profitability.
    - Increased share repurchase commitment to $400 million to $500 million for 2026, reflecting confidence in long-term strategy.

    4) Challenges and Market Headwinds
    - Continued softness in the capital equipment market and macroeconomic uncertainties impacting Systems and Services revenue.
    - The U.K. VAT ruling resulted in a $37.5 million liability, with VAT reintroduced on applicable products.
    - North American retail demand remains stable but is a focus area for growth initiatives.

    5) Guidance and Outlook
    - Q3 2026 revenue expected between $1 billion and $1.020 billion, with mid-single-digit growth in Clear Aligner volumes.
    - Full-year 2026 revenue growth projected at 3% to 4% YoY, with Systems and Services revenue expected to decline 6% to 8% YoY.
    - The company anticipates continued growth in iTero scanner shipments and Clear Aligner volumes, supported by strategic initiatives.

    Bottom line: Align Technology is positioned for continued growth in Clear Aligners, driven by strong international performance and strategic initiatives, despite facing challenges in the Systems and Services segment and macroeconomic headwinds. Shareholders can expect a focus on innovation and governance improvements to enhance long-term value.

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Align Technology — Financial Overview, Stock Price, Market Cap

    Align Technology is a company. Founded in 1997. As of August 14, 2026, the company's market capitalization is $12619113977 with a current stock price of $176.20.